From: Pan-cancer analysis of TCGA data reveals notable signaling pathways
Cancer | Tumor samples | Non-tumor samples | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Ind. | Asn. | Blk. | Haw. | Wht. | NA | Ind. | Asn. | Blk. | Haw. | Wht. | NA |
Breast cancer | 1 | 34 | 39 | 0 | 303 | 89 | 0 | 0 | 1 | 0 | 59 | 1 |
Colon adenocarcinoma | 0 | 0 | 1 | 0 | 9 | 133 | 0 | 0 | 2 | 0 | 8 | 9 |
Glioblastoma | 0 | 13 | 34 | 0 | 495 | 25 | 0 | 0 | 0 | 0 | 0 | 10 |
Kidney renal papillary cell carcinoma | 0 | 0 | 0 | 0 | 9 | 7 | 0 | 0 | 0 | 0 | 0 | 0 |
Low grade glioma | 0 | 0 | 2 | 0 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Lung adenocarcinoma | 0 | 2 | 1 | 0 | 26 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
Lung squamous cell carcinoma | 0 | 3 | 7 | 0 | 91 | 53 | 0 | 0 | 0 | 0 | 0 | 0 |
Ovarian carcinoma | 3 | 19 | 24 | 1 | 493 | 32 | 0 | 0 | 0 | 0 | 0 | 8 |
Rectum adenocarcinoma | 0 | 0 | 1 | 0 | 4 | 64 | 0 | 0 | 0 | 0 | 3 | 0 |
Uterine corpus endometriod carcinoma | 2 | 4 | 6 | 0 | 40 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Pan-cancer (total) | 6 | 75 | 115 | 1 | 1495 | 408 | 0 | 0 | 3 | 0 | 70 | 28 |